UBS upgraded DaVita from Neutral to Buy and set a new price target of $142.00 from $100.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/6/2024 | $133.00 | Equal Weight | Barclays |
| 8/7/2023 | $100.00 → $142.00 | Neutral → Buy | UBS |
| 11/1/2022 | $97.00 → $72.00 | Buy → Hold | Deutsche Bank |
| 10/31/2022 | $117.00 → $74.00 | Buy → Neutral | UBS |
| 8/19/2022 | $106.00 → $117.00 | Buy | UBS |
| 6/21/2022 | $110.00 → $90.00 | Underperform | BofA Securities |
| 1/5/2022 | $114.00 → $125.00 | Hold | Truist Securities |
| 10/29/2021 | $113.00 → $111.00 | Sector Perform | RBC Capital |
4 - DAVITA INC. (0000927066) (Issuer)
4 - DAVITA INC. (0000927066) (Issuer)
4 - DAVITA INC. (0000927066) (Issuer)